Peter Veng‐Pedersen

2.3k total citations
93 papers, 1.8k citations indexed

About

Peter Veng‐Pedersen is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Peter Veng‐Pedersen has authored 93 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 20 papers in Genetics and 18 papers in Physiology. Recurrent topics in Peter Veng‐Pedersen's work include Erythropoietin and Anemia Treatment (22 papers), Hemoglobinopathies and Related Disorders (19 papers) and Analytical Chemistry and Chromatography (17 papers). Peter Veng‐Pedersen is often cited by papers focused on Erythropoietin and Anemia Treatment (22 papers), Hemoglobinopathies and Related Disorders (19 papers) and Analytical Chemistry and Chromatography (17 papers). Peter Veng‐Pedersen collaborates with scholars based in United States, Netherlands and Hong Kong. Peter Veng‐Pedersen's co-authors include William R. Gillespie, John A. Widness, Nishit B. Modi, Robert L. Schmidt, Kevin J. Freise, Demet Nalbant, Ronald A. Herman, Dorothy D. Schottelius, Daniel E. Fürst and John L. Hoffman and has published in prestigious journals such as Environmental Science & Technology, Blood and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Peter Veng‐Pedersen

93 papers receiving 1.7k citations

Peers

Peter Veng‐Pedersen
Paolo Ventura Italy
Ivan Nestorov United States
Thorir D. Bjornsson United States
Ronald de Vries Belgium
Ulf G. Eriksson Sweden
Wojciech Krzyżański United States
Yuji Kumagai Japan
Joachim Stangier Germany
Michael Spino Canada
Otto Bekers Netherlands
Paolo Ventura Italy
Peter Veng‐Pedersen
Citations per year, relative to Peter Veng‐Pedersen Peter Veng‐Pedersen (= 1×) peers Paolo Ventura

Countries citing papers authored by Peter Veng‐Pedersen

Since Specialization
Citations

This map shows the geographic impact of Peter Veng‐Pedersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Veng‐Pedersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Veng‐Pedersen more than expected).

Fields of papers citing papers by Peter Veng‐Pedersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Veng‐Pedersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Veng‐Pedersen. The network helps show where Peter Veng‐Pedersen may publish in the future.

Co-authorship network of co-authors of Peter Veng‐Pedersen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Veng‐Pedersen. A scholar is included among the top collaborators of Peter Veng‐Pedersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Veng‐Pedersen. Peter Veng‐Pedersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carroll, Patrick D., M. Bridget Zimmerman, Demet Nalbant, et al.. (2020). Neonatal Umbilical Arterial Catheter Removal Is Accompanied by a Marked Decline in Phlebotomy Blood Loss. Neonatology. 117(3). 294–299. 4 indexed citations
2.
Li, Xueshu, Xianai Wu, Kevin M. Kelly, Peter Veng‐Pedersen, & Hans‐Joachim Lehmler. (2019). Toxicokinetics of Chiral PCB 136 and Its Hydroxylated Metabolites in Mice with a Liver-Specific Deletion of Cytochrome P450 Reductase. Chemical Research in Toxicology. 32(4). 727–736. 13 indexed citations
3.
4.
Widness, John A., Demet Nalbant, Robert L. Schmidt, et al.. (2017). Estimation of adult and neonatal RBC lifespans in anemic neonates using RBCs labeled at several discrete biotin densities. Pediatric Research. 81(6). 905–910. 19 indexed citations
5.
An, Guohua, John A. Widness, Donald M. Mock, & Peter Veng‐Pedersen. (2016). A Novel Physiology-Based Mathematical Model to Estimate Red Blood Cell Lifespan in Different Human Age Groups. The AAPS Journal. 18(5). 1182–1191. 11 indexed citations
6.
Elkomy, Mohammed H., John A. Widness, & Peter Veng‐Pedersen. (2011). Pharmacokinetic Analysis of Continuous Erythropoietin Receptor Activator Disposition in Adult Sheep Using a Target-Mediated, Physiologic Recirculation Model and a Tracer Interaction Methodology. Drug Metabolism and Disposition. 39(4). 603–609. 10 indexed citations
7.
Hoffman, Robert P., et al.. (2009). Noncompartmental pharmacokinetics analysis of glucose‐stimulated insulin response in African–American and Caucasian youths. Biopharmaceutics & Drug Disposition. 30(3). 117–125. 1 indexed citations
8.
Veng‐Pedersen, Peter, et al.. (2009). Analysis of PK/PD risk factors for development of type 2 diabetes in high risk population using Bayesian analysis of glucose–insulin kinetics. Journal of Pharmacokinetics and Pharmacodynamics. 36(5). 421–441. 2 indexed citations
9.
Freise, Kevin J., Robert L. Schmidt, John A. Widness, & Peter Veng‐Pedersen. (2008). Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response. Journal of Pharmacokinetics and Pharmacodynamics. 35(5). 527–552. 4 indexed citations
10.
Al‐Huniti, Nidal, John A. Widness, Robert L. Schmidt, & Peter Veng‐Pedersen. (2005). Pharmacodynamic Analysis of Changes in Reticulocyte Subtype Distribution in Phlebotomy-Induced Stress Erythropoiesis. Journal of Pharmacokinetics and Pharmacodynamics. 32(3-4). 359–376. 21 indexed citations
11.
Bechensteen, Anne Grete, Sunny Chapel, Peter Veng‐Pedersen, & John A. Widness. (2004). Posttransfusion recovery of stored red blood cells in very low birth weight infants using a hemoglobin balance model. Transfusion. 44(7). 1019–1024. 1 indexed citations
12.
Veng‐Pedersen, Peter, et al.. (1995). Duration of Opioid Antagonism by Nalmefene and Naloxone in the Dog: An Integrated Pharmacokinetic/Pharmacodynamic Comparison. Journal of Pharmaceutical Sciences. 84(9). 1101–1106. 11 indexed citations
13.
Veng‐Pedersen, Peter & Nishit B. Modi. (1993). Application of Neural Networks to Pharmacodynamics. Journal of Pharmaceutical Sciences. 82(9). 918–926. 52 indexed citations
14.
Kling, Pamela J., et al.. (1992). Pharmacokinetics and pharmacodynamics of erythropoietin during therapy in an infant with renal failure. The Journal of Pediatrics. 121(5). 822–825. 12 indexed citations
15.
Veng‐Pedersen, Peter & Nishit B. Modi. (1992). Pharmacodynamic System Analysis of the Biophase Level Predictor and the Transduction Function. Journal of Pharmaceutical Sciences. 81(9). 925–934. 14 indexed citations
16.
Veng‐Pedersen, Peter & Lloyd Tillman. (1989). Center of Gravity of Drug Level Curves: A Model-Independent Parameter Useful in Bioavailability Studies. Journal of Pharmaceutical Sciences. 78(10). 848–854. 7 indexed citations
17.
Veng‐Pedersen, Peter. (1989). Mean Time Parameters Dealing with the Tissue Distribution of Drugs: Limitations and Extensions. Journal of Pharmaceutical Sciences. 78(3). 264–266. 9 indexed citations
18.
Veng‐Pedersen, Peter. (1989). Mean Time Parameters in Pharmacokinetics. Clinical Pharmacokinetics. 17(6). 424–440. 46 indexed citations
19.
Gillespie, William R., Peter Veng‐Pedersen, Edward J. Antal, & J. Paul Phillips. (1988). A system approach to pharmacodynamics II: Glyburide pharmacodynamics and estimation of optimal drug delivery. Journal of Pharmaceutical Sciences. 77(1). 48–55. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Ventura Breakdown of academic impact, for papers by Ivan Nestorov Breakdown of academic impact, for papers by Thorir D. Bjornsson Breakdown of academic impact, for papers by Ronald de Vries Breakdown of academic impact, for papers by Ulf G. Eriksson Breakdown of academic impact, for papers by Wojciech Krzyżański Breakdown of academic impact, for papers by Yuji Kumagai Breakdown of academic impact, for papers by Joachim Stangier Breakdown of academic impact, for papers by Michael Spino Breakdown of academic impact, for papers by Otto Bekers
Rankless by CCL
2026